tirzepatide in mash the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once-weekly in persons with metabolic Emerging Role of GLP-1 Receptor

For the treatment to be successful, patients need to be overweight

Bone health should be considered during significant weight loss, particularly in older adults or those with osteoporosis risk factors

What results can patients expect after taking GLP-1 medications

CardioNerds Journal Club is a monthly forum for CardioNerds to discuss and breakdown recent publications on twitter and are produced with a corresponding infographic and detailed blog post

Some recommend dropping back one dose level for safety, then returning to your previous dose if tolerated well

It's simpler than it looks, and it's all about understanding the relationship between the total amount of peptide, the amount of water you added, and the volume you'll draw into your syringe